Active substance
Results for the substance canagliflozin metformin
4 results
About this active substance
Canagliflozin and metformin are used together for the treatment of type 2 diabetes, providing more effective blood sugar control. This combination combines the effects of the SGLT2 inhibitor (canagliflozin) and the biguanide (metformin).
Canagliflozin reduces glucose reabsorption in the kidneys, eliminating excess glucose through urine, while metformin decreases glucose production in the liver and improves insulin sensitivity.
The medication is taken orally, usually twice daily, with meals to reduce the risk of gastrointestinal side effects. It is important to follow the doctor's instructions and monitor blood sugar levels.
Side effects may include nausea, diarrhea, urinary tract infections, or, in rare cases, diabetic ketoacidosis or lactic acidosis. Patients should inform their doctor of any unusual symptoms.
Canagliflozin reduces glucose reabsorption in the kidneys, eliminating excess glucose through urine, while metformin decreases glucose production in the liver and improves insulin sensitivity.
The medication is taken orally, usually twice daily, with meals to reduce the risk of gastrointestinal side effects. It is important to follow the doctor's instructions and monitor blood sugar levels.
Side effects may include nausea, diarrhea, urinary tract infections, or, in rare cases, diabetic ketoacidosis or lactic acidosis. Patients should inform their doctor of any unusual symptoms.
-
-
VOKANAMET 50mg/1000mg film-coated tablets CILAG ORIGINAL MEDICINE
-
VOKANAMET 150mg/1000mg film-coated tablets CILAG ORIGINAL MEDICINE
-
VOKANAMET 150mg/850mg film-coated tablets CILAG ORIGINAL MEDICINE